ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

"Heart disease takes years to decades to develop, and the process starts in the younger years," one heart doctor told us. Here, cardiologists share their best-kept secrets to set up your ticker for a ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

In the 1960s, an obscure Scandinavian researcher identified a peculiar blood fat particle that became known as lipoprotein(a) ...

In the long term, regular binge drinking can also increase your risk of becoming dependent on alcohol, alcohol-related cancer and heart disease. Sign up to our fortnightly Heart Matters newsletter to ...